Clinigen Group Plc (CLIN.L)
| Previous close | 905.00 |
| Open | 898.00 |
| Bid | 891.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 895.50 - 906.50 |
| 52-week range | 541.50 - 948.05 |
| Volume | |
| Avg. volume | 1,885,679 |
| Market cap | 1.208B |
| Beta (5Y monthly) | 1.47 |
| PE ratio (TTM) | 40.63 |
| EPS (TTM) | 22.30 |
| Earnings date | 21 Feb 2022 - 25 Feb 2022 |
| Forward dividend & yield | 0.08 (0.82%) |
| Ex-dividend date | 02 Dec 2021 |
| 1y target est | 795.55 |
- Business Wire
Form 8.5 (EPT/NON-RI) - Clinigen Group plc
LONDON, January 21, 2022-- FORM 8.5 (EPT/NON-RI)
- Bloomberg
Triton Sweetens Clinigen Bid to Persuade Biggest Investors
(Bloomberg) -- Triton Investment Management raised its offer for Clinigen Group Plc to win the backing of shareholders including activist Elliott Investment Management, but the stock declined amid doubts that the sweetened bid will sway key investors. Most Read from BloombergDeadly Drone Strikes on UAE Raise Gulf Tensions, Roil Oil MarketFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial SuggestsOne of the World’s Wealthiest Oil Exporters Is Becoming UnlivableOlympic Ticket Sa
- Reuters
UK's Clinigen agrees to sweetened $1.8 billion Triton take-private deal
Shareholders in Clinigen, whose top investor is hedge fund Elliott, will receive 925 pence per share in cash, up from a December bid of 883 pence apiece. New York-based Elliott, which had been raising its holding in Clinigen over the past few months amid reports it was seeking a break-up of the group, owns a 10.5% stake in the British company, according to Refintiv Eikon data. The latest offer by Triley Bidco, a newly created company indirectly owned by Triton Funds, is final and is recommended by the Clinigen board, the companies said in a joint statement.
